Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
eNq1mG9v2jAQxt/zKaK8Jwn0D+kUqDbWbkitymjRpr1BJjmKWWqnZxvoPv0cQldaGZUa/DJx8tzF99zPpyTny4fcmwMKylnbbwSR7wFLeUbZfdsf3l3WY/+8U0tmZE42HmsFUdBo+l6aEyHafrkajIEwEfy6vvoK+n1Av1PzEj6eQSpfPackzYPvREyvSVE+4yVzTjPvAeSUZ22/UHJ110uERJ1FZ8HxjyhICkm4vrO5Ohsdb95PwlJsB1UlAK8IuzeKTtBKM1WIwGSXSLjn+GSWTkfNuHUaRbFVCCoGILjCFPpETvvI5zSDzByJ5AKsgkwW2S3gPAdZBjGKh7P0QViJkxlZDuCxZ076s17tyqWsR/VGq3UaN1txdHLaaFiFwo2tMptHf0RYFJiNmmfxyVF0Ek4wpKxcFKQuQUguJCBnYFmsPkdJckdloqL72nCO4iA8vmuHjIoiJ0/BTBS2W0WQ6GVAjQV3H1J+wR1qUOV6z97oM5Xn4QezHq4x4ijjklJdrrQjzTS5HNhuRJczCcvtFbUDoFyuvUhBHE7275sG/L/QV+OcpraM0xRSusWHg952xDmlwxciYIju8PCTsowvxOGxs1lmR9kXK3IaRYuRrkV8dmR/8P/WNdtyAF0o5AWEmkZU7AOZHpvwffGiPWqWenaoO3OuxiOekhy2DEh1S/RoVz7Pc858766nqgWj6LeLO1u//FCAT7erS6M0zdqblbZDswvea4O+l3vVx+39erYS2WGuPo6PmnZ+RzNrplIW4lMYLhaLYEpEXRC9jYFutd0Ph/ODbIGm7ksF3c39TsaCakyqoOso9XF1lH6shrb9+t7gsO8wvH5/PXQbY0hUsEctKrQ7A3Dv4vBMf5mEnaXdf4UZd2FWUyuRlDNXw5Mam2G87ymiS8suNdTkzWRCt/yR2WrNJKz+BnVqSVj+CerU/gHhxRS2
unD9Uu4emCfdAkGm